Tradestie Institutional Equity Comparison Engine

ATAI vs NUVB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATAI Overall Edge

ATAI Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ATAI Life Sciences N.V. Common Shares (ATAI) driven by superior Momentum & Technical, Options & Structure while NUVB counters with relative strength in Growth & Margin. Fundamentally, ATAI trades at N/M Forward P/E with -2590.4% operating margin (+137.0% YoY revenue) versus NUVB at N/M Forward P/E and -61.2% operating margin (+242.6% YoY). In options structure, ATAI sits in UNCLASSIFIED (38th %ile IV; Dealer Gamma Walls on Pro) against NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ATAI N/M vs NUVB N/M Fwd P/E
Growth & Margin Winner NUVB
Op Margin -2590.4% vs -61.2% ยท YoY +137.0% vs +242.6%
Momentum & Technical Winner ATAI
1Y +50.3% vs -46.9% ยท 52W Pos 98% vs 2%
Options & Structure Winner ATAI
UNCLASSIFIED (38th %ile IV) vs BREAKDOWN (26th %ile IV)
ATAI NASDAQ
ATAI Life Sciences N.V. Common Shares
Pharmaceutical Preparations
$7.35
+0.82% 1D
Market Cap $2.7B
1M Return +1.94%
1Y Return +50.31%
Forward P/E N/M
Unified AI Score
45.7 / 100 HOLD
Tech 34.0 Fund 47.0 Flow 59.0 Mom 50.0
NUVB NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap $1.3B
1M Return -19.15%
1Y Return -46.85%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 53.0 Fund 61.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATAI +50.31% NUVB -46.85% Spread: +104.58 pp (ATAI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ATAI Revenue NUVB Revenue ATAI Op. Margin NUVB Op. Margin Margin Edge
FY2024 $0M $10M -33341.2% -7527.3% NUVB
FY2025 $0M $60M -15751.1% -338.7% NUVB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATAI (4) vs NUVB (4)
Institutional Metric ATAI NUVB Criterion Row Winner
Market Capitalization Scale $2.7B $1.3B Larger Scale ATAI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +137.0% +242.6% Higher Growth NUVB
Operating Margin (TTM) Profitability -2590.4% -61.2% Higher Margin NUVB
Net Profit Margin Profitability 0.0% -67.4% Higher Margin ATAI
Return on Equity (ROE) Capital Efficiency -417.2% -49.1% Higher ROE NUVB
52-Week Range Position Momentum 98% ($3โ€“$7) 2% ($4โ€“$10) Stronger Trend ATAI
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 10% Vol 1.52ฮฒ ยท 55% Vol Lower Realized Risk ATAI
Unified Institutional Score Composite Signal 45.7 / 100 (HOLD) 61.0 / 100 (BUY) Higher Composite NUVB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATAI vs NUVB Buy Guide
ATAI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATAI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NUVB BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NUVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATAI nor NUVB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.